UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): November 8, 2007
Gen-Probe Incorporated
(Exact Name of Registrant as Specified in Charter)
| |
|
|
|
|
| Delaware
|
|
001-31279
|
|
33-0044608 |
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification No.) |
| |
|
|
|
|
|
|
|
10210 Genetic Center Drive
San Diego, CA
(Address of Principal Executive Offices)
|
92121
(Zip Code) |
|
(858) 410-8000
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
TABLE OF CONTENTS
Item 8.01 Other Events
On November 8, 2007, Gen-Probe Incorporated (the “Company”) issued a news release announcing
that 3M Company has informed the Company it no longer intends to fund the companies’ collaboration
to develop rapid molecular assays for the food testing industry. The companies expect to formally
terminate the collaboration in the coming days. A copy of the news release is attached as Exhibit
99.1 to this Current Report on Form 8-K.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| |
|
|
| Exhibit No. |
|
Description |
99.1
|
|
News release dated November 8, 2007 |
Forward-Looking Statements
Any statements in this Current Report about our expectations, beliefs, plans, objectives,
assumptions, future events or performance are not historical facts and are forward-looking
statements. These statements are often, but not always, made through the use of words or phrases
such as believe, will, expect, anticipate, estimate, intend, plan and would. For example,
statements concerning management’s objectives and future growth are forward-looking statements.
Forward-looking statements are not guarantees of performance. They involve known and unknown risks,
uncertainties and assumptions that may cause actual results, levels of activity, performance or
achievements to differ materially from those expressed or implied by any forward-looking statement.
Some of the risks, uncertainties and assumptions that could cause actual results to differ
materially from estimates or projections in the forward-looking statement include, but are not
limited to: (i) the risk that molecular testing methods will not penetrate the food testing market,
(ii) the risk that development efforts for MRSA or other projects may not be timely or successful,
(iii) the possibility that new products will not be competitive or gain market acceptance, and (iv)
the risk that collaborations cannot be maintained. For additional information about risks and
uncertainties we face and a discussion of our financial statements and footnotes, see documents we
have filed with the SEC, including our Report on Form 10-K for the fiscal year ended December 31,
2006 and all our periodic filings made with the SEC. We assume no obligation and expressly disclaim
any duty to update forward-looking statements to reflect events or circumstances after the date of
this Current Report or to reflect the occurrence of subsequent events.